Related Experiment Video
Updated: Jul 26, 2026
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.7K
Causal inference between immune cells and glioblastoma: a bidirectional Mendelian randomization study
Shiqiang Hou1, Chunjing Jin2, Beitian Shi1
1Department of Neurosurgery, The Affiliated Chuzhou Hospital of Anhui Medical University, The First People's Hospital of Chuzhou, Chuzhou, China.
Journal of Cancer
|January 2, 2025
Summary
This study used genetic analysis to find causal links between 16 immune cell types and Glioblastoma (GBM). These findings offer insights into GBM immunology and potential immunotherapy targets.
Area of Science:
- Neuro-oncology
- Immunology
- Genetics
Background:
- Glioblastoma (GBM) and the immune system have a complex relationship.
- The precise mechanisms underlying this interaction remain largely undefined.
- Understanding these links is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the causal relationship between Glioblastoma (GBM) and various immune cells.
- To utilize bidirectional Mendelian randomization (MR) analysis for robust causal inference.
- To identify specific immunophenotypes associated with GBM risk and progression.
Main Methods:
- Employed genome-wide association study (GWAS) data for GBM and 731 immunophenotypes.
- Conducted bidirectional Mendelian randomization (MR) analysis using Inverse Variance Weighted (IVW) and False Discovery Rate (FDR) methods.
- Performed sensitivity analyses to ensure the reliability and validity of the results.
Main Results:
- Identified seven immunophenotypes causally associated with GBM risk, including specific markers on T cells and myeloid cells.
- Reverse MR analysis revealed nine immunophenotypes strongly linked to GBM, involving B cell markers (BAFF-R) and myeloid cell markers (CCR2).
- A total of 16 distinct immunophenotypes demonstrated a significant causal inference with GBM.
Conclusions:
- Confirmed a causal relationship between 16 specific immunophenotypes and Glioblastoma (GBM) using genetic evidence.
- Provides a foundational understanding for future research in GBM immunology.
- Offers potential targets and guidance for the development of novel GBM immunotherapies.
